Bannerman B, Xu L, Jones M, et al. (2011). Preclinical Evaluation of the Antitumor Activity of Bortezomib In Combination With Vitamin C or With Epigallocatechin Gallate, A Component of Green Tea. Cancer Chemotherapy and Pharmacology, 68(5) 1145-1154.
Berenson JR, Boccia R, Siegel D, et al. (2006). Efficacy and Safety of Melphalan, Arsenic Trioxide and Ascorbic Acid Combination Therapy in Patients With Relapsed or Refractory Multiple Myeloma: A Prospective, Multicentre, Phase II, Single-Arm Study. British Journal of Haematology, 135(2) 174-183.
Cullen JJ, Spitz DR, & Buettner GR (2011) Comment on “Pharmacologic Ascorbate Synergizes With Gemcitabine in Preclinical Models of Pancreatic Cancer,” i.e., All We Are Saying is, Give C a Chance. Free Radical Biology & Medicine, 50(12) 1726-7.
Fritz H, Flower G, Weeks L, et al. (2014) Intravenous Vitamin C and Cancer: A Systematic Review. Integrative Cancer Therapies, 13(4) 280-300
Hoffer LJ, Robitaille L, Zakarian R, et al. (2015) High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial. PLOS One, 10(4)
Jacobs C, Hutton B, Ng T, et al. (2015). Is There A Role for Oral or Intravenous Ascorbate (Vitamin C) in Treating Patients with Cancer? A Systematic Review. The Oncologist, 20(2) 210-23.
Kawada H, Sawanobori M, Tsuma-Kaneko M, et al. (2014) Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin’s Lymphoma. The Tokai Journal of Experimental and Clinical Medicine, 39(3) 111-5.
Leekha A, Gurjar BS, Tyagi A, et al. (2016) Vitamin C in Synergism With Cisplatin Induces Cell Death in Cervical Cancer Cells Through Altered Redox Cycling and p53 Upregulation. Journal of Cancer Research and Clinical Oncology, 142(12) 2503-2514.
Ma Y, Chapman J, Levine M, et al. (2014) High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy. Science Translational Medicine, 6, 222.)
Monti DA, Mitchell E, Bazzan AJ, Littman S, et al. (2012) Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer. PLOS One, 7(1)
Moss R, (2006) Should Patients Undergoing Chemotherapy and Radiotherapy Be Prescribed Antioxidants? Integrative Cancer Therapies, 5(1) 63-82.
Muralikrishnan G, Amanullah S, Basha M, et al. (2010). Effect of Vitamin C On Lipidperoxidation and Antioxidant Status in Tamoxifen-Treated Breast Cancer Patients. Chemotherapy, 56(4) 298-302.
Stephenson CM, Levin RD, Spector T, Lis CG (2013) Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of High-Dose Intravenous Ascorbic Acid in Patients with Advanced Cancer. Cancer Chemotherapy and Pharmacology, 72(1) 139-146.
Vollbracht C, Schneider B, Leendert V, et al. (2011) Intravenous Vitamin C Administration Improves Quality of Life in Breast Cancer Patients During Chemo-/Radiotherapy and Aftercare: Results of a Retrospective, Multicentre, Epidemiological Cohort Study in Germany. In Vivo, 25, (6) 383-990
Wagner SC, Markosian B, Ajili N, et al. (2014) Intravenous Ascorbic Acid As An Adjuvant to Interleukin-2 Immunotherapy. Journal of Translational Medicine, 12: 127
